Abstract:Currently, 33 gene‐therapy drugs/products have been approved in the clinic. Over 3000 completed and ongoing clinical gene therapy trials have been reported worldwide. The development/maturation of tools for gene manipulation and gene delivery, as well as molecular advances in the diagnosis of genetic diseases, have played a central role in gene therapy, which have greatly revolutionized the field. Versatile and diverse genetic tools for gene manipulations and deliveries, with the possibility of short and long‐term effects, are vital advantages of gene therapy tools, paving the road for the development of new therapies. However, efficacy and safety concerns, immune system responses, laborious approaches for developing and manufacturing, unknown gene‐therapy drug interactions with the host and the high cost of drugs/products, are significant barriers in gene therapy. Here, the authors review the attempts for engineering of the gene manipulations that have been undertaken in the last three decades and used in clinical trials focusing on 1) gene‐editing platforms, 2) viral gene delivery systems, and 3) nonviral gene tools. In this comprehensive review, the principles of these gene manipulation tools as well as advances and barriers for their application in modern therapies are discussed. Furthermore, trends and future directions in gene therapy are discussed. This review discusses genetic tools, which have been used in clinical gene therapy trials during the last three decades. These tools include gene‐editing platforms, viral gene delivery vehicles, and nonviral tools. Furthermore, their advances and barriers as well as trends and future directions in modern gene therapy are emphasized.

Clinical translation of gene medicine

Viral vector‐based gene therapies in the clinic

Research Progress of Gene Therapy in Clinical Application

Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

Development and clinical translation of ex vivo gene therapy

Gene Therapy:the Present and Prospect

Current developments of gene therapy in human diseases

How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?

Production and Clinical Development of Nanoparticles for Gene Delivery

Successes and challenges in clinical gene therapy

Clinical and Translational Landscape of Viral Gene Therapies

Historical And Clinical Experiences Of Gene Therapy For Solid Cancers In China

The Approved Gene Therapy Drugs Worldwide: from 1998 to 2019

Gene Therapy: Regulations, Ethics and Its Practicalities in Liver Disease

Section Review—Oncologic, Endocrine & Metabolic: Gene Therapy Strategies for Cancer

Advance in Gene Therapy of Tumors

Advancements in Gene Therapy for Human Disease: Trend of Current Clinical Trials

Engineering Gene Therapy: Advances and Barriers

Viral vector platforms within the gene therapy landscape

Applications and Developments of Gene Therapy Drug Delivery Systems for Genetic Diseases

Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects